Posts by Erica Seiguer Shenoy, MD, PhD
-
Diagnostic Algorithm Supports Evaluation of Hospitalized COVID-19 Patients After Initial Negative Test
Researchers at Massachusetts General Hospital have developed the Covid Risk cALculator (CORAL), a diagnostic algorithm and clinical decision support system for evaluating hospitalized adults under investigation for COVID-19 who have had at least one negative SARS-CoV-2 nucleic acid amplification test (NAAT).
-
What Is a Superspreader Event?
The primary mode of transmission of SARS-Cov-2 is close contact between persons. Accordingly, there has been a heavy emphasis on effective non-pharmaceutical interventions. Breakdowns in physical distancing and gatherings have been associated with significant numbers of infections.
-
Time, Symptom-based Protocols Optimal to Determine Return to Work After COVID-19 Infection
Investigators at Massachusetts General Hospital found that the "time-plus-symptoms" approach allows health care workers who have been infected with COVID-19 to return to work sooner than a "test-based" approach would allow.
-
Study Examines the Prevalence of COVID-19 Infections in Pregnant Women About to Give Birth
Research published in Infection Control & Hospital Epidemiology reports the prevalence of COVID-19 infections in pregnant women admitted to Massachusetts General Hospital's labor and delivery units. They found that 7.9% of symptomatic women tested positive and 1.5% of asymptomatic women tested positive.
-
Still No Definitive Evidence of Airborne Transmission of the Novel Coronavirus
Massachusetts General Hospital clinicians review the literature on transmission of SARS-CoV-2 and highlight that the presence of SARS-CoV-2 RNA in air samples does not necessarily mean the virus can be effectively transmitted via the airborne route.
-
How is SARS-CoV-2 transmitted?
Knowledge of an emerging pathogen’s mode of transmission is paramount for the development of effective infection control guidelines and public health policies to protect our health care facilities and communities.
-
Why Mass General Neurologists Are Animated About Big Data
Neurologists at Massachusetts General Hospital are using big data and machine learning to make better and more informed decisions on patient care.
Biography
Dr. Erica S. Shenoy is an Associate Physician at the Massachusetts General Hospital where she specializes in the evaluation and management of infections among both hospitalized and ambulatory patients. Dr. Shenoy sees patients in the Infectious Diseases clinic at the Mass General Main Campus on Mondays, and is available for follow up, initial consultations and second opinions.
Dr. Shenoy is Associate Chief of the Infection Control Unit at Mass General and an Assistant Professor at Harvard Medical School. She is board certified in infectious diseases and internal medicine. She is additionally trained as a health economist. Dr. Shenoy is a principal investigator on several grants and leads an active research team evaluating the clinical, operational and economic impact of infection control strategies for multi-drug resistant organisms.
Dr. Shenoy has a leadership role in the Mass General planning and response to Ebola Virus Disease (EVD) and other special pathogens. She is responsible for development of hospital policies and procedures emerging infectious diseases and has worked closely with staff from across the institution in planning meetings, training, and drills and exercises. As Medical Director of the Mass General Biothreats Care Unit (BCU), one of 10 federally funded special pathogens programs in the United States, Dr. Shenoy is responsible for the overall operations of the BCU, including the implementation of awarded grants. She liaises with the hospital’s Incident Management Team and Hospital Incident Command System as needed.